Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFu Jen Catholic University
About this trial
This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients requiring thoracentesis for pleural effusion drainage as determined by a physician based on clinical need.
Signed informed consent.
Disqualifiers
Patients under the age of 18.
Patients with malignancies other than lung adenocarcinoma.
Trial population
The control group consists of non-malignant pleural effusion, while the case group includes those diagnosed with pleural effusion with lung adenocarcinoma.
Trial design
Design model
Case-control
Time perspective
Prospective
Treatments tested in this trial
biomarkers
Other interventionpleural effusion biomarkers in lung adenocarcinoma
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: Case group1 intervention
Group B: Control group1 intervention
Trial outcomes
Primary outcomes
1
target gene expression levels between malignant and non-malignant pleural effusions
Novel biomarkers specifically expressed in malignant pleural effusions may provide additional diagnostic options for malignant lung cancer in clinical diagnosis
Time frame
20 minutesSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov